Sharps Technology, Inc. (NASDAQ:STSS) Short Interest Up 38.6% in November

Sharps Technology, Inc. (NASDAQ:STSS) was the target of a significant growth in short interest in the month of November. As of November 15th, there was short interest totalling 60,000 shares, a growth of 38.6% from the October 31st total of 43,300 shares. Based on an average daily volume of 81,700 shares, the days-to-cover ratio is presently 0.7 days. Currently, 3.5% of the company’s stock are sold short.

Institutional Trading of Sharps Technology

An institutional investor recently bought a new position in Sharps Technology stock. Garden State Investment Advisory Services LLC bought a new position in Sharps Technology, Inc. (NASDAQ:STSS) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 172,909 shares of the company’s stock, valued at approximately $26,000. Garden State Investment Advisory Services LLC owned 9.61% of Sharps Technology at the end of the most recent reporting period. Institutional investors and hedge funds own 17.17% of the company’s stock.

Sharps Technology Stock Down 5.2 %

STSS stock traded down $0.21 during midday trading on Friday, hitting $3.76. 14,359 shares of the company’s stock were exchanged, compared to its average volume of 187,408. The company has a market capitalization of $6.76 million, a PE ratio of -0.47 and a beta of 1.19. Sharps Technology has a 12-month low of $2.34 and a 12-month high of $18.15.

Sharps Technology Company Profile

Sharps Technology, Inc, a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc was incorporated in 2017 and is based in Melville, New York.